National Cancer Institute; Notice of Meeting, 11363 [2017-03387]
Download as PDF
Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices
therapy, or as needing alternative
treatment strategies.
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, the National
Cancer Institute receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR part 404.
Complete applications for a license in
the prospective field of use that are filed
in response to this notice will be treated
as objections to the grant of the
contemplated Exclusive Patent License
Agreement. Comments and objections
submitted to this notice will not be
made available for public inspection
and, to the extent permitted by law, will
not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: February 15, 2017.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2017–03402 Filed 2–21–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov/).
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 21, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Acting Director’s Report: Ongoing
and New Business; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Room 10, Bethesda, MD 20892.
VerDate Sep<11>2014
16:05 Feb 21, 2017
Jkt 241001
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Rm. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 22, 2017.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: Acting Director’s Report: Ongoing
and New Business; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Rm. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 15, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03387 Filed 2–21–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
11363
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Clinical Trials and Translation
Research Advisory Committee, March 8,
2017, 8:00 a.m. to March 8, 2017, 3:00
p.m., National Institutes of Health,
Building 31, C-Wing, 6th Floor, Rooms
9 and 10, 31 Center Drive, Bethesda, MD
20892 which was published in the
Federal Register on January 11, 2017, 81
FR 3342.
This meeting notice is amended to
change the meeting format and start and
end times. The meeting will now be
held virtually from 11:00 a.m. to 1:30
p.m. due to a change in the agenda
which reduced the time required for
deliberation and discussion. The
meeting will still be held at the National
Institutes of Health, Building 31, CWing, 6th Floor, Rooms 9 and 10, 31
Center Drive, Bethesda, MD 20892 and
can also be accessed via NIH Videocast
at https://videocast.nih.gov. This
meeting is open to the public.
Dated: February 16, 2017.
Melanie J. Gray-Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03448 Filed 2–21–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Second Stage
P01 Review.
Date: March 15, 2017.
Frm 00028
Fmt 4703
Sfmt 4703
E:\FR\FM\22FEN1.SGM
22FEN1
Agencies
[Federal Register Volume 82, Number 34 (Wednesday, February 22, 2017)]
[Notices]
[Page 11363]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The meeting will also be videocast and can be
accessed from the NIH Videocasting and Podcasting Web site (https://videocast.nih.gov/).
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 21, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Acting Director's Report: Ongoing and New Business; RFA
and RFP Concept Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Rm. 7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 22, 2017.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: Acting Director's Report: Ongoing and New Business; RFA
and RFP Concept Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Rm. 7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 15, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-03387 Filed 2-21-17; 8:45 am]
BILLING CODE 4140-01-P